Cargando…
OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767576/ http://dx.doi.org/10.1186/1742-4690-6-S3-O52 |
| _version_ | 1782173326403174400 |
|---|---|
| author | de Souza, MS Trichavaroj, R Schuetz, A Chuenarom, W Phuang-ngem, Y Jongrakthaitae, S Ratto-Kim, S Nitayaphan, S Dally, L Rerks-Ngam, S Tartaglia, J Francis, D Michael, NL Paris, RM Kim, JH |
| author_facet | de Souza, MS Trichavaroj, R Schuetz, A Chuenarom, W Phuang-ngem, Y Jongrakthaitae, S Ratto-Kim, S Nitayaphan, S Dally, L Rerks-Ngam, S Tartaglia, J Francis, D Michael, NL Paris, RM Kim, JH |
| author_sort | de Souza, MS |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27675762009-10-28 OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial de Souza, MS Trichavaroj, R Schuetz, A Chuenarom, W Phuang-ngem, Y Jongrakthaitae, S Ratto-Kim, S Nitayaphan, S Dally, L Rerks-Ngam, S Tartaglia, J Francis, D Michael, NL Paris, RM Kim, JH Retrovirology Oral Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767576/ http://dx.doi.org/10.1186/1742-4690-6-S3-O52 Text en Copyright © 2009 BioMed Central Ltd. |
| spellingShingle | Oral Presentation de Souza, MS Trichavaroj, R Schuetz, A Chuenarom, W Phuang-ngem, Y Jongrakthaitae, S Ratto-Kim, S Nitayaphan, S Dally, L Rerks-Ngam, S Tartaglia, J Francis, D Michael, NL Paris, RM Kim, JH OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial |
| title | OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial |
| title_full | OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial |
| title_fullStr | OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial |
| title_full_unstemmed | OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial |
| title_short | OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial |
| title_sort | oa07-04 lb. immunogenicity of alvac-hiv® (vcp1521) and aidsvax® b/e prime boose vaccination in rv144, the thai phase iii hiv vaccine trial |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767576/ http://dx.doi.org/10.1186/1742-4690-6-S3-O52 |
| work_keys_str_mv | AT desouzams oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT trichavarojr oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT schuetza oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT chuenaromw oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT phuangngemy oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT jongrakthaitaes oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT rattokims oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT nitayaphans oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT dallyl oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT rerksngams oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT tartagliaj oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT francisd oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT michaelnl oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT parisrm oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial AT kimjh oa0704lbimmunogenicityofalvachivvcp1521andaidsvaxbeprimeboosevaccinationinrv144thethaiphaseiiihivvaccinetrial |